Published: Apr 07, 2021
LONDON, April 7, 2021 /PRNewswire/ In September 2020 biotech start-up COVIMRO Ltd demonstrated the effectiveness of its food-grade compound, Covimro, against Coronavirus.
Now the same compound has been shown to be equally effective against other viruses as demonstrated in recent scientific studies. In March 2021, Covimro was tested for antiviral efficacy against Lentivirus / HIV with a Luciferase Assay. The results show a 3-log reduction in viral titre at all concentrations tested.
This preliminary data warrants further investigation in to the Covimro effect, said Dr. Senthil Chinnakannan, a molecular virologist at the University of Oxford.
The structural stability and integrity of a virus are crucial in order for it to infect a target cell. Covimro breaches the structural integrity of the virus leading to its rapid inactivation.